Conversion Surgery for Metastatic Gastric Cancer at 2 Years After Initial

Conversion Surgery for Metastatic Gastric Cancer at 2 Years After Initial

Suzuki et al. surg case rep (2021) 7:62 https://doi.org/10.1186/s40792-021-01145-3 CASE REPORT Open Access Conversion surgery for metastatic gastric cancer at 2 years after initial diagnosis of cancer of unknown primary with metastasis of cervical lymph nodes and ovary: a case report Masaki Suzuki1* , Hisashi Hosaka2, Yasuyuki Fukai1, Yasushi Mochida1, Daigo Ozawa1, Norimichi Kogure1, Kazunosuke Yamada1 and Hitoshi Ojima1 Abstract Background: Patients with stage IV gastric cancer have a poor prognosis despite improvements in intensive treat- ment regimens, including chemotherapy. Recently, conversion surgery has received much attention as it can provide long-term survival in stage IV gastric cancer patients who are responsive to chemotherapy. Herein, we describe the case of a patient who underwent conversion surgery for metastatic gastric cancer that was performed over 2 years after an initial diagnosis of cancer of unknown primary (CUP) with metastasis of the cervical lymph nodes and the ovary. Case presentation: A 67-year-old woman with cervical lymphadenopathy was referred to our hospital. Computed tomography showed left cervical lymphadenopathy and bilateral ovarian enlargement. Endoscopic survey revealed no signs of malignancy in the upper or the lower gastrointestinal tract. Pathological fndings after cervical lym- phadenectomy revealed a signet-ring cell carcinoma and were suggestive of gastric cancer metastases. However, multiple evaluations yielded no evidence of gastric cancer and the patient was diagnosed with CUP. She was pre- scribed chemotherapy for gastric cancer and underwent bilateral oophorectomy after undergoing chemotherapy for 18 months. Pathologic analysis of oophorectomy tissue revealed fndings identical to those seen in the cervical lymph nodes. At about 2 years after the initial diagnosis, an esophagogastroduodenoscopy revealed evidence of gastric cancer. We performed a distal gastrectomy with D2 lymphadenectomy. Her postoperative course was uneventful and she remains alive with no signs of disease recurrence at 3 months post-surgery. Conclusions: To the best of our knowledge, this is the frst report describing successful conversion surgery for stage IV gastric cancer in a patient whose cancer was defnitively diagnosed 2 years after an initial diagnosis of CUP. Keywords: Gastric cancer, Cancer of unknown primary, Conversion surgery, Distal gastrectomy, Cervical lymph node metastases, Ovarian metastases, Krukenberg tumor Background Despite early diagnosis and improved intensive treat- ments, gastric cancer remains a leading cause of malignancy-related death worldwide [1]. Most gastric cancer patients are not eligible for radical surgery due *Correspondence: [email protected] 1 Department of Gastroenterological Surgery, Gunma Prefectural Cancer to the presence of locally advanced or metastatic dis- Center, 617-1, Nishimach, Oota, Gunma 373-0828, Japan ease [2]. With the development of multiple therapeu- Full list of author information is available at the end of the article tic approaches, standard treatment for gastric cancer is © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. Suzuki et al. surg case rep (2021) 7:62 Page 2 of 6 described in the Japanese treatment guidelines for gastric also unremarkable. To make a defnite diagnosis, we per- cancer [3]. Recently, conversion surgery has emerged as a formed a lymphadenectomy of the left cervical region promising strategy that can provide long-term survival in and pathological analysis revealed the presence of signet- patients with stage IV gastric cancer who are responsive ring cells and a poorly diferentiated adenocarcinoma, to chemotherapy [4]. which were suggestive of metastases originating from Although there are a few case reports on conversion gastric cancer (Fig. 1b). However, fuorodeoxyglucose surgery for gastric cancer [5–7], none describe a case that (FDG) positron emission computed tomography (PET– was initially diagnosed as cancer of unknown primary CT) showed no abnormal uptake, and although we could (CUP). Here we report a case of successful conversion not detect a primary lesion at that point, we recom- surgery that was performed after a cervical lymphad- mended chemotherapy pertinent to gastric cancer. enectomy and a bilateral oophorectomy, wherein defni- Te patient received monotherapy with oral S-1 tive diagnosis of gastric cancer could only be established (100 mg/body/day) for the frst 4 weeks of a 6-week cycle, about 2 years after an initial diagnosis of CUP. and after three courses of chemotherapy, CT showed a reduction in ovarian metastases without the appear- Case presentation ance of new lesions; however, EGD continued to reveal A 67-year-old woman with left cervical lymphadenopa- no signs of gastric cancer. Although treatment with S-1 thy was referred to our hospital for further evaluation was efective, the patient complained of general fatigue, following a diagnosis of signet-ring cell carcinoma after which was accompanied by an elevation in liver enzymes, a needle biopsy at a local medical doctor. Te patient had and she was diagnosed as being allergic to S-1. Her an Eastern Cooperative Oncology Group Performance chemotherapy regimen was switched to nab-paclitaxel Status of 0. Her serum carbohydrate antigen (CA) 19-9 (nab-PTX), which consisted of a 4-week course of intra- and carcinoembryonic antigen (CEA) levels were 16.8 U/ venous nab-PTX (100 mg/body) on days 1, 8, and 15. ml and 2.5 ng/ml, respectively. Ultrasonography revealed While continuing this regimen for 18 months, the bilat- three instances of lymph node enlargement in the left eral ovarian metastases remained stable. As there was cervical area (Fig. 1a). Computed tomography (CT) no evidence of other lesions, including in the stomach, showed left cervical lymphadenopathy and bilateral ovar- we performed a bilateral oophorectomy. Tere were no ian enlargement (Fig. 2a), but without specifc signs of remarkable changes in gastric serosa and surrounding gastric cancer or lymph node metastasis surrounding the tissues of stomach and microscopic examination of the stomach. Esophagogastroduodenoscopy (EGD) revealed specimen confrmed a diagnosis of metastatic adenocar- only slight atrophy of the stomach and there were no cinoma that consisted of a signet-ring cell carcinoma and fndings that indicated gastric cancer. Colonoscopy was a poorly diferentiated adenocarcinoma (Fig. 2b). Tese Fig. 1 Ultrasonography and pathological fndings in cervical lymph nodes. a Ultrasonography showed three pieces of lymph node enlargement in left cervical area (arrow). b Pathological fndings revealed signet-ring cell and a poorly diferentiated adenocarcinoma ( 400 magnifcation) × Suzuki et al. surg case rep (2021) 7:62 Page 3 of 6 Fig. 2 Computed tomography (CT) and pathological fndings in the ovary. a Abdominal CT showed bilateral ovarian enlargement with uterine calcifcation due to myoma. b Pathological fndings revealed signet-ring cells and a poorly diferentiated adenocarcinoma ( 400 magnifcation) × fndings again suggested the presence of a primary gas- gastric body (Fig. 3a). Biopsy specimens revealed a poorly tric lesion. diferentiated adenocarcinoma with signet-ring cells Te patient was carefully followed up with continued (Fig. 3b), and this was considered as evidence of gastric chemotherapy (nab-PTX). At 3 months after the oopho- cancer. Nonetheless, CT showed no specifc changes in rectomy, we detected a limited rough-surfaced mucosa the stomach or in the nearby lymph nodes and PET–CT with slight redness near the pyloric ring that stained pos- also showed no abnormal uptake in the whole body. We itive for indigo carmine during endoscopic examination discussed the possibility of a R0 resection and decided to without any abnormality in other areas of antrum and perform conversion surgery. We discussed the method of Fig. 3 Esophagogastroduodenoscopy and pathological fndings in the stomach. a Esophagogastroduodenoscopy showed limited rough-surfaced mucosa with slight redness changes near the pyloric ring (arrow) that stained positive for indigo carmine staining (arrow). There were no specifc signs in other areas of antrum and gastric body. b Biopsy specimens revealed a poorly diferentiated adenocarcinoma with signet-ring cells ( 200 × magnifcation) Suzuki et al. surg case rep (2021) 7:62 Page 4 of 6 surgery, and decided to proceed with distal gastrectomy CUP is defned as histologically confrmed meta- considering the postoperative nutrition and absence of static tumors whose primary site cannot be identifed obvious signs that indicate the extent of the cancer in the upon standard pretreatment evaluation [8]. CUP occurs upper area. roughly equally in men and women, with an

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    6 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us